FDA commissioner: Health systems have to ‘step up’ on AI regulation or will ‘end up holding the bag’
Sept. 11, 2024
Health Tech Reporter
WELLESLEY, Mass. — Amid heated discussions on how artificial intelligence should be regulated and who should be involved in health care AI governance, the U.S. Food and Drug Administration commissioner said that health systems need to take a leading role.
“I think there’s a lot of good reason for health systems to be concerned that if they don’t step up, they’re going to end up holding the bag on liability when these algorithms go wrong,” said Robert Califf on Tuesday to a group of journalists in Wellesley, Mass.
advertisement
Developers can’t fully guarantee the algorithm’s performance, explained Califf, because an AI model’s performance evolves over time and performs differently in different hospitals’ patient populations, unlike a drug. And that model drift is “happening in health systems. And so for the health system to say, ‘This is just a manufacturer [problem],’ then the whole thing will break down and won’t work,” he said.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Monthly
$39
Totals $468 per year
$39/month Get StartedTotals $468 per year
Starter
$20
for 3 months, then $399/year
$20 for 3 months Get StartedThen $399/year
Annual
$399
Save 15%
$399/year Get StartedSave 15%
11+ Users
Custom
Savings start at 25%!
Request A Quote Request A QuoteSavings start at 25%!
2-10 Users
$300
Annually per user
$300/year Get Started$300 Annually per user
View All Plans
To read the rest of this story subscribe to STAT+.
Subscribe Log In Artificial intelligence, FDA, STAT+ Submit a correction requestReprints
Newsletter
Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve.
